- Home
- ALGS vs PAVM Comparison
ALGS vs PAVM Comparison
Compare ALGS & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | PAVM |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 41.1M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALGS | PAVM |
|---|---|---|
| Price | $5.58 | $2.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $52.38 | $36.50 |
| AVG Volume (30 Days) | ★ 39.1K | 23.8K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,186,000.00 | ★ $3,000,000.00 |
| Revenue This Year | $1,562.10 | $132.39 |
| Revenue Next Year | N/A | $263.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $3.98 | $0.21 |
| 52 Week High | $13.69 | $28.44 |
Technical Indicators
Market Signals| Indicator | ALGS | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | N/A |
| Support Level | $4.81 | N/A |
| Resistance Level | $6.12 | N/A |
| Average True Range (ATR) | 0.38 | 0.00 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 58.78 | 0.00 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.